Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant chemoradiation for gastric cancer: multicentric study of the Anatolian Society of Medical Oncology.
Kucukoner M, Isikdogan A, Arpaci E, Bilici M, Uncu D, Cetin B, Dane F, Inane M, Kaplan MA, Cayir K, Yetisyigit T, Ozdemir N, Inal A, Aksoy S, Alkis N, Tekin SB, Eroglu C, Turhal S, Benekli M, Buyukberber S. Kucukoner M, et al. Among authors: buyukberber s. Hepatogastroenterology. 2012 Oct;59(119):2343-7. doi: 10.5754/hge11709. Hepatogastroenterology. 2012. PMID: 22389301
Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology multicenter study.
Inal A, Ciltas A, Yildiz R, Berk V, Kos FT, Dane F, Unek IT, Colak D, Ozdemir NY, Buyukberber S, Gumus M, Ozkan M, Isikdogan A. Inal A, et al. Among authors: buyukberber s. Asian Pac J Cancer Prev. 2012;13(5):1841-4. doi: 10.7314/apjcp.2012.13.5.1841. Asian Pac J Cancer Prev. 2012. PMID: 22901133 Free article.
Lapatinib plus capecitabine for brain metastases in patients with human epidermal growth factor receptor 2-positive advanced breast cancer: a review of the Anatolian Society of Medical Oncology (ASMO) experience.
Cetin B, Benekli M, Oksuzoglu B, Koral L, Ulas A, Dane F, Turker I, Kaplan MA, Koca D, Boruban C, Yilmaz B, Sevinc A, Berk V, Isıkdogan A, Uncu D, Harputluoglu H, Coskun U, Buyukberber S. Cetin B, et al. Among authors: buyukberber s. Onkologie. 2012;35(12):740-5. doi: 10.1159/000345040. Epub 2012 Oct 31. Onkologie. 2012. PMID: 23207619 Free article.
Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients.
Uncu D, Aksoy S, Çetin B, Yetişyiğit T, Özdemir N, Berk V, Dane F, Inal A, Harputluoğlu H, Budakoğlu B, Koca D, Sevinç A, Cihan S, Durnalı AG, Özkan M, Öztürk MA, Işıkdoğan A, Büyükberber S, Benekli M, Köş T, Alkış N, Karaca H, Turhal NS, Zengin N; Anatolian Society of Medical Oncology. Uncu D, et al. Among authors: buyukberber s. Oncology. 2013;84(4):240-5. doi: 10.1159/000336902. Epub 2013 Feb 7. Oncology. 2013. PMID: 23392240 Clinical Trial.
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.
Yildiz R, Kalender ME, Dane F, Sevinc A, Gumus M, Camci C, Alici S, Kaya AO, Yaman E, Ozturk B, Coskun U, Benekli M, Uncu D, Buyukberber S. Yildiz R, et al. Among authors: buyukberber s. J Oncol Pharm Pract. 2010 Sep;16(3):173-8. doi: 10.1177/1078155209347402. Epub 2009 Oct 15. J Oncol Pharm Pract. 2010. PMID: 19833685
Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer.
Kaya AO, Buyukberber S, Dane F, Isikdogan A, Ustaalioglu BO, Coskun U, Yumuk PF, Dogu GG, Ozdemir NY, Sevinc A, Gumus M, Ozkan M, Yildiz R, Ozturk B, Yaman E, Benekli M; Anatolian Society of Medical Oncology. Kaya AO, et al. Among authors: buyukberber s. Tumori. 2010 May-Jun;96(3):400-4. doi: 10.1177/030089161009600304. Tumori. 2010. PMID: 20845799
197 results